Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation.

Dengue is the most frequent hemorrhagic viral disease and re-emergent infection in the world. Although thrombocytopenia is characteristically observed in mild and severe forms of dengue, the role of platelet activation in dengue pathogenesis has not been fully elucidated. We hypothesize that platelets have major roles in inflammatory amplification and increased vascular permeability during severe forms of dengue. Here we investigate interleukin (IL)-1β synthesis, processing, and secretion in platelets during dengue virus (DV) infection and potential contribution of these events to endothelial permeability during infection. We observed increased expression of IL-1β in platelets and platelet-derived microparticles from patients with dengue or after platelet exposure to DV in vitro. We demonstrated that DV infection leads to assembly of nucleotide-binding domain leucine rich repeat containing protein (NLRP3) inflammasomes, activation of caspase-1, and caspase-1-dependent IL-1β secretion. Our findings also indicate that platelet-derived IL-1β is chiefly released in microparticles through mechanisms dependent on mitochondrial reactive oxygen species-triggered NLRP3 inflammasomes. Inflammasome activation and platelet shedding of IL-1β-rich microparticles correlated with signs of increased vascular permeability. Moreover, microparticles from DV-stimulated platelets induced enhanced permeability in vitro in an IL-1-dependent manner. Our findings provide new evidence that platelets contribute to increased vascular permeability in DV infection by inflammasome-dependent release of IL-1β.

[1]  A. Weyrich,et al.  Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC‐SIGN and caspases , 2013, Journal of thrombosis and haemostasis : JTH.

[2]  C. Morrell,et al.  Platelet Induction of the Acute-Phase Response Is Protective in Murine Experimental Cerebral Malaria , 2013, The Journal of Immunology.

[3]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[4]  Lei Li,et al.  CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. , 2013, Blood.

[5]  A. Basu,et al.  NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis , 2012, PloS one.

[6]  Holly Anderton,et al.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. , 2012, Immunity.

[7]  G. Waris,et al.  Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex. , 2012, The Journal of general virology.

[8]  A. Osterhaus,et al.  Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  Ken Jacobson,et al.  Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. , 2011, Blood.

[10]  V. Dixit,et al.  Modulation of Inflammasome Pathways by Bacterial and Viral Pathogens , 2011, The Journal of Immunology.

[11]  A. Weyrich,et al.  Platelets in dengue infection , 2011 .

[12]  T. McIntyre,et al.  Lipopolysaccharide Signaling without a Nucleus: Kinase Cascades Stimulate Platelet Shedding of Proinflammatory IL-1β–Rich Microparticles , 2011, The Journal of Immunology.

[13]  M. Bertrand,et al.  cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production , 2011, Cell Death and Differentiation.

[14]  J. Freedman,et al.  Platelets and the immune continuum , 2011, Nature Reviews Immunology.

[15]  Haitao Wen,et al.  The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.

[16]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[17]  Robert A. Campbell,et al.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum , 2011, Seminars in Immunopathology.

[18]  K. Martin,et al.  [Comparison of the transcriptional profiles of patients with dengue fever and dengue hemorrhagic fever reveals differences in the immune response and clues in immunopathogenesis]. , 2011, Biomedica : revista del Instituto Nacional de Salud.

[19]  A. Schmidt Response to dengue fever--the good, the bad, and the ugly? , 2010, The New England journal of medicine.

[20]  Yi-Ling Lin,et al.  The Interferon Stimulator Mitochondrial Antiviral Signaling Protein Facilitates Cell Death by Disrupting the Mitochondrial Membrane Potential and by Activating Caspases , 2009, Journal of Virology.

[21]  G. Perng,et al.  A Re‐evaluation of the Mechanisms Leading to Dengue Hemorrhagic Fever , 2009, Annals of the New York Academy of Sciences.

[22]  S. Kalayanarooj,et al.  Characteristics of dengue virus‐infected peripheral blood mononuclear cell death that correlates with the severity of illness , 2009, Microbiology and immunology.

[23]  F. Chan,et al.  Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.

[24]  D. Liu,et al.  Gene expression profiling by microarray analysis reveals an important role for caspase‐1 in dengue virus‐induced p53‐mediated apoptosis , 2009, Journal of medical virology.

[25]  P. Fontana,et al.  Cell-derived microparticles in haemostasis and vascular medicine , 2009, Thrombosis and Haemostasis.

[26]  A. Nisalak,et al.  Detection of dengue virus in platelets isolated from dengue patients. , 2009, The Southeast Asian journal of tropical medicine and public health.

[27]  P. Shashkin,et al.  Lipopolysaccharide Is a Direct Agonist for Platelet RNA Splicing1 , 2008, The Journal of Immunology.

[28]  Fernando A Bozza,et al.  Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity , 2008, BMC infectious diseases.

[29]  M. Guzmán,et al.  Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever‐dengue shock syndrome (DHF/DSS) , 2007, Immunology and cell biology.

[30]  Nigel Mackman,et al.  Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets , 2006, The Journal of experimental medicine.

[31]  C. Romero-Vivas,et al.  Altered Enzyme-Linked Immunosorbent Assay Immunoglobulin M (IgM)/IgG Optical Density Ratios Can Correctly Classify All Primary or Secondary Dengue Virus Infections 1 Day after the Onset of Symptoms, when All of the Viruses Can Be Isolated , 2006, Clinical and Vaccine Immunology.

[32]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[33]  A. Larson The epidemiology of hepatocellular carcinoma in hcv , 2005 .

[34]  K. Swoboda,et al.  Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.

[35]  Christian Weber,et al.  Platelet Microparticles: A Transcellular Delivery System for RANTES Promoting Monocyte Recruitment on Endothelium , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[36]  Katherine I. Schexneider,et al.  Thrombocytopenia in dengue fever. , 2005, Current hematology reports.

[37]  A. Weyrich,et al.  The evolving role of platelets in inflammation , 2003, Journal of thrombosis and haemostasis : JTH.

[38]  Ting-Hsiang Lin,et al.  Comparison of Capture Immunoglobulin M (IgM) and IgG Enzyme-Linked Immunosorbent Assay (ELISA) and Nonstructural Protein NS1 Serotype-Specific IgG ELISA for Differentiation of Primary and Secondary Dengue Virus Infections , 2003, Clinical Diagnostic Laboratory Immunology.

[39]  J. V. D. van der Meer,et al.  The Role of Cytokines in Activation of Coagulation and Fibrinolysis in Dengue Shock Syndrome , 2002, Thrombosis and Haemostasis.

[40]  R. North,et al.  Rapid secretion of interleukin-1β by microvesicle shedding , 2001 .

[41]  R. North,et al.  Rapid secretion of interleukin-1beta by microvesicle shedding. , 2001, Immunity.

[42]  E. Remold-O’Donnell,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Role of Caspase in a Subset of Human Platelet Activation Responses , 1999 .

[43]  A. Bretscher,et al.  Dynamic association of moesin with the membrane skeleton of thrombin- activated platelets. , 1999, Blood.

[44]  A. Bretscher,et al.  Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain , 1999, FEBS letters.

[45]  A. Nisalak,et al.  Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.

[46]  R. He,et al.  Antibody-enhanced binding of dengue-2 virus to human platelets. , 1995, Virology.

[47]  A. Nurden,et al.  Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups , 1993 .

[48]  C. Dinarello,et al.  Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. , 1993, Blood.

[49]  G. Kuno,et al.  An ELISA procedure for the diagnosis of dengue infections. , 1991, Journal of virological methods.

[50]  R. McEver,et al.  GMP-140 mediates adhesion of stimulated platelets to neutrophils. , 1990, Blood.

[51]  N. Sangkawibha,et al.  Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. , 1977, The American journal of tropical medicine and hygiene.